CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology® (CST) where we discuss what to expect from your time at the bench, share tips, tricks, and information.

All Posts

Mechanisms of Cell Death: Ferroptosis

Ferroptosis is a recently described form of programmed cell death with distinct morphological and biochemical characteristics. It does not result in the chromatin condensation observed during apoptosis or the loss of plasma membrane integrity that occurs during necrosis. Rather, it is morphologically characterized by the presence of condensed mitochondria, reduction in mitochondrial cristae, and increased membrane densities.

Ferratin & Iron Homeostasis

Ferroptosis is an iron-dependent cell death that results in an increase in lipid peroxides. As such, it is largely regulated by pathways that contribute to iron homeostasis and oxidative stress. Iron homeostasis is controlled, in part, by ferratin, which is a large protein complex that is responsible for the transport of iron in its non-toxic form. Ferratin levels can be regulated by a selective autophagy process targeting ferratin, termed ferritinophagy. This pathway is mediated by a selective cargo receptor for ferratin called nuclear receptor coactivator 4 (NCOA4). Ferroptosis has been shown to be inhibited with the use of some common iron chelators, such as deferoamine.

Defense against Oxidative Stress

Pathways regulating cellular defense against oxidative stress are critical to mitigate ferroptosis. Small-molecule lipophilic free radical scavengers, like ferrostatin-1 and liproxstatin-1, can inhibit ferroptosis. The glutathione pathway, in particular, has been identified as a key antioxidant defense pathway. A central player in this process is the metabolic protein glutathione peroxidase 4 (GPX4), which converts GSH into oxidized glutathione (GSSH), thus protecting cells against ferroptosis by limiting cytotoxic lipid peroxidation. The glutathione peroxidase pathway is further regulated by System Xc-, an amino acid antiporter consisting of a heterodimer of xCT/SLC7A11 and SLC3A2 (4F2hc/CD98), which is critical for glutathione (GSH) synthesis. Importantly, one way to induce ferroptosis is to use the compound erastin that directly inhibits the function of System Xc-.

Regulation of genes involved in oxidative stress, including GPX4, are largely controlled by the transcription factor NRF2. This serves as a critical defense against ferroptosis. Under normal conditions, expression of NRF2 is inhibited through interaction with KEAP1, part of a ubiquitin E3 ligase complex that leads to NRF2 proteasomal degradation. Oxidative stress leads to conformation changes in KEAP1 that disrupts this interaction, resulting in stabilization of NRF2. This process is further regulated through the autophagy pathway in which the autophagy cargo receptor p62/SQSTM1 can competitively inhibit the KEAP1-NRF2 complex leading to upregulation of NRF2.

Tools for Studying Ferroptosis

Tools to monitor ferroptosis may involve multiple approaches, including pharmacological sensitivity (such as iron chelators, antioxidants), changes in expression of targets (GPX4, SCL7A11, ferratin, NRF2, etc.), monitoring reactive oxygens and lipid peroxidation, and glutathione assays.

To find out more about the mechanisms, morphology, and target proteins involved in many types of cell death, download the Researcher's Guide to Mechanisms of Cell Death.

Read additional blogs in this Cell Death series here, on Apoptosis, Necrosis & Necroptosis, and Pyroptosis.

20-CEP-94379 Guide to Mechanism of Cell Death

Select Reviews

Galluzzi, L. et al. (2018) Cell Death & Differentiation 25, 486–541.

Frank, D. and Vince, J. Cell Death & Differentiation (2019) 26, 99–114.

Escobar, M. L., Echeverría, O. M., and Vázquez-Nin, G. H. (Dec 16th, 2015)


Yang, W. S. and Stockwell, B. R. (2016) Trends Cell Biol. 26(3), 165–176.

Gary K.
Gary K.
Dr. Gary Kasof is a Senior Research Fellow working on antibody development and has been at CST for over 17 years. He has contributed to the release of nearly 1000 antibodies in several research areas, most notable in cell death and autophagy. Prior to CST he received his PhD from Columbia University in 1995, and has worked at Rutgers University and AstraZeneca.

Related Posts

Therapeutic Approaches for the Treatment of Multiple Myeloma

What Is Multiple Myeloma? Multiple myeloma is a cancer of plasma cells that is treatable, but not curable...
Andrea T Jul 2, 2022 5:16:45 PM

Hypoxia and Its Role in Metabolism

Hypoxia, defined as the deficiency of oxygen in the biotic environment, causes cellular stress and alters...
Chris S Jun 8, 2022 3:00:00 AM

It's All about the Affinity

In 2012 Roux et al. published in the Journal of Cell Biology a pioneering approach to identify the intera...
Charles F May 25, 2022 3:00:00 AM